home / stock / dgx / dgx articles

DGX Articles, Quest Diagnostics Incorporated - From 03/18/24

Stock Information
Company Name: Quest Diagnostics Incorporated
Stock Symbol: DGX
Market: NYSE
Website: questdiagnostics.com
Menu
DGX DGX Quote DGX Short DGX News DGX Articles DGX Message Board
Get DGX Alerts

News, Short Squeeze, Breakout and More Instantly...
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow | Benzinga

Bond appetites are growing as more and more investors look to lock in high-yielding assets ahead of an expected decline in interest rates this year...
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Investor Sentiment Falls Sharply Following Fed's Rate Decision; Dow Dips Over 300 Points | Benzinga

The CNN Money Fear and Greed index showed a sharp decline in the overall market sentiment, while the index remained in the "Greed" zone o...

Quest Diagnostics Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts | Benzinga

Quest Diagnostics Incorporated (NYSE: DGX) is expected to release earnings results for its fourth quarter, before the opening bell on Feb. 1, 2024....
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns | Benzinga

A new era in Alzheimer’s diagnosis is on the horizon as Dr. Suzanne Schindler and her team at Washington University School of Medic...

Consulting Firm McKinsey Concludes Opioid Litigation Settlement With $78M Agreement | Benzinga

Consulting giant McKinsey & Co, on Friday, agreed to a settlement of $78 million to resolve allegations tied to the opioid epidemic, as di...

Quest Diagnostics Gains Momentum: Analyst Highlights Strong Business Trends And Growth Opportunities | Benzinga

Truist Securities analyst David S. MacDonald reiterated a Hold rating on Quest Diagnostics Incorporated (NYSE: DGX), raising th...
Supreme Court Set to Decide Future of Mifepristone: Showdown Looms Over FDA's Endorsement | Benzinga

The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.&nb...

Quest Diagnostics and CDC Expand Public Health Research Collaboration to Better Understand Hepatitis C Burden in the United States | Benzinga

Quest will provide research consulting, laboratory testing and data analytics services to generate diagnostics insights supporting population healt...

Opioid Crisis and Corporate Accountability: Purdue's Settlement in the Spotlight | Benzinga

The U.S. Supreme Court is reviewing a contentious bankruptcy settlement involving Purdue Pharma, the maker of OxyContin, and its owners, the&n...
Previous 10 Next 10